Metropolitan Life Insurance CO Beam Therapeutics Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$23.46 - $45.07 $8,680 - $16,675	-370 Reduced 8.77%	3,847 $127,000
Q3 2023 Nov 14, 2023	BUY	$23.01 - $32.46 $11,113 - $15,678	483 Added 12.94%	4,217 $101,000
Q2 2023 Aug 10, 2023	BUY	$29.32 - $35.99 $6,098 - $7,485	208 Added 5.9%	3,734 $119,000
Q1 2023 May 15, 2023	SELL	$30.15 - $48.79 $12,120 - $19,613	-402 Reduced 10.23%	3,526 $107,000
Q4 2022 Jun 14, 2023	BUY	$36.73 - $51.6 $14,765 - $20,743	402 Added 11.4%	3,928 $154 Million
Q4 2022 Mar 30, 2023	BUY	$36.73 - $51.6 $3,379 - $4,747	92 Added 2.4%	3,928 $153,000
Q4 2022 Feb 15, 2023	BUY	$36.73 - $51.6 $3,379 - $4,747	92 Added 2.4%	3,928 $153,000
Q3 2022 Jun 14, 2023	BUY	$39.79 - $70.31 $12,334 - $21,796	310 Added 8.79%	3,836 $183 Million
Q2 2022 Jun 20, 2023	BUY	$29.86 - $62.36 $9,256 - $19,331	310 Added 8.79%	3,836 $148,000
Q2 2022 Mar 30, 2023	BUY	$29.86 - $62.36 $17,079 - $35,669	572 Added 17.52%	3,836 $148,000
Q2 2022 Aug 11, 2022	BUY	$29.86 - $62.36 $17,079 - $35,669	572 Added 17.52%	3,836 $148,000
Q1 2022 Jun 20, 2023	SELL	$53.73 - $82.16 $14,077 - $21,525	-262 Reduced 7.43%	3,264 $187,000
Q1 2022 Mar 30, 2023	SELL	$53.73 - $82.16 $528,112 - $807,550	-9,829 Reduced 75.07%	3,264 $187,000
Q1 2022 May 12, 2022	SELL	$53.73 - $82.16 $528,112 - $807,550	-9,829 Reduced 75.07%	3,264 $187,000
Q4 2021 Jun 21, 2023	BUY	$68.02 - $99.06 $650,747 - $947,707	9,567 Added 271.33%	13,093 $1.04 Million
Q3 2021 Jun 21, 2023	BUY	$84.37 - $133.6 $807,167 - $1.28 Million	9,567 Added 271.33%	13,093 $1.14 Million
Q3 2021 Mar 30, 2023	BUY	$84.37 - $133.6 $19,236 - $30,460	228 Added 1.77%	13,093 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $19,236 - $30,460	228 Added 1.77%	13,093 $1.14 Million
Q2 2021 Jun 21, 2023	BUY	$64.12 - $128.71 $598,816 - $1.2 Million	9,339 Added 264.86%	12,865 $1.66 Million
Q2 2021 Mar 30, 2023	BUY	$64.12 - $128.71 $130,035 - $261,023	2,028 Added 18.71%	12,865 $1.66 Million
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $824,198 - $1.65 Million	12,854 Added 116854.55%	12,865 $1.66 Million
Q1 2021 Jun 26, 2023	BUY	$71.28 - $120.75 $521,128 - $882,803	7,311 Added 207.35%	10,837 $867 Million
Q1 2021 Mar 30, 2023	SELL	$71.28 - $120.75 $30,080 - $50,956	-422 Reduced 3.75%	10,837 $867,000
Q1 2021 May 14, 2021	SELL	$71.28 - $120.75 $801,757 - $1.36 Million	-11,248 Reduced 99.9%	11 $867,000
Q4 2020 Jun 22, 2023	BUY	$22.24 - $95.63 $171,981 - $739,506	7,733 Added 219.31%	11,259 $919,000
Q4 2020 Mar 30, 2023	BUY	$22.24 - $95.63 $15,679 - $67,419	705 Added 6.68%	11,259 $919,000
Q4 2020 Feb 16, 2021	BUY	$22.24 - $95.63 $15,679 - $67,419	705 Added 6.68%	11,259 $919,000
Q3 2020 Jun 26, 2023	BUY	$19.0 - $30.57 $133,532 - $214,845	7,028 Added 199.32%	10,554 $259,000
Q3 2020 Mar 30, 2023	BUY	$19.0 - $30.57 $111,568 - $179,507	5,872 Added 125.42%	10,554 $259,000
Q3 2020 Nov 13, 2020	BUY	$19.0 - $30.57 $111,568 - $179,507	5,872 Added 125.42%	10,554 $260,000
Q2 2020 Jun 26, 2023	BUY	$15.26 - $28.66 $17,640 - $33,130	1,156 Added 32.79%	4,682 $131,000
Q1 2020 Jul 12, 2023	BUY	$13.31 - $29.2 $15,386 - $33,755	1,156 Added 32.79%	4,682 $84,000
Q1 2020 Mar 30, 2023	BUY	$13.31 - $29.2 $10,035 - $22,016	754 Added 19.2%	4,682 $84,000
Q1 2020 May 15, 2020	BUY	$13.31 - $29.2 $62,317 - $136,714	4,682 New	4,682 $84,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

Farallon Capital Management LLC San Francisco, CA

8.21M
Shares

$208 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.84M
Shares

$198 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.63M
Shares

$193 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

6.53M
Shares

$165 Million
1.52% of portfolio
Arch Venture Management, LLC Chicago, IL

4.83M
Shares

$122 Million
71.21% of portfolio

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account